250 microCi quantities of [6- 3 H]-Uridine Diphospho-D-Glucose are available for your research.
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0445066-V3
- Awardee
- REVVITY HEALTH SCIENCES, INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $6,248
About this award
The University of Virginia awarded contract A207_PO-0445066-V3 to Revvity Health Sciences, Inc., effective August 1, 2026. The contract calls for the delivery of 6,247 units of [6-³H]-Uridine Diphospho-D-Glucose, a radioactively labeled biochemical compound used in research applications. The cumulative contract value is $6,247.74, with a unit price of $1.00 per unit. Delivery is to be made to the buyer at the University of Virginia in Virginia.
This contract represents a straightforward procurement of specialized research materials for the University of Virginia's research initiatives. The radioactive glucose derivative specified is commonly utilized in molecular and cellular research to trace metabolic pathways and biochemical processes. The award demonstrates the University's engagement with commercial suppliers for specialized laboratory reagents necessary to support ongoing research programs within the institution.
Line items
| Item | Total |
|---|---|
| 250 microCi quantities of [6- 3 H]-Uridine Diphospho-D-Glucose are available for your research. | $6,247.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0445066-V3?
Contract A207_PO-0445066-V3 was awarded to REVVITY HEALTH SCIENCES, INC. by University of Virginia on August 1, 2026.
How much is contract A207_PO-0445066-V3 worth?
Its cumulative value is $6,248.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award